Difficulty: Medium
Average Score: 81%
Practice
Which of the following hypnotic agents is a positive allosteric modulator of GABAA receptor function?
Correct answer
D
Rationale
In pharmacology, understanding the mechanisms of action of drugs is crucial for safe and effective prescribing. In this case, the correct answer is D) All of the above. Zaleplon, Flurazepam, and Zolpidem are all hypnotic agents that act as positive allosteric modulators of the GABAA receptor function.
These drugs enhance the inhibitory effects of GABA, the main inhibitory neurotransmitter in the central nervous system, by binding to specific sites on the GABAA receptor complex. By increasing GABAergic transmission, these agents promote sedation, anxiolysis, and muscle relaxation, making them effective in treating insomnia and other sleep disorders.
Option A, Zaleplon, is a nonbenzodiazepine hypnotic that acts specifically on the benzodiazepine site of the GABAA receptor. Option B, Flurazepam, is a benzodiazepine that also acts as a positive allosteric modulator of the GABAA receptor. Option C, Zolpidem, is a nonbenzodiazepine hypnotic that, like Zaleplon, targets the benzodiazepine site on the GABAA receptor.
Educationally, knowing the specific pharmacological properties of these drugs is vital for healthcare professionals to make informed decisions when selecting the most appropriate treatment for patients with sleep disorders. Understanding how these agents interact with the GABAA receptor provides a solid foundation for safe prescribing practices and optimizing patient outcomes.
These drugs enhance the inhibitory effects of GABA, the main inhibitory neurotransmitter in the central nervous system, by binding to specific sites on the GABAA receptor complex. By increasing GABAergic transmission, these agents promote sedation, anxiolysis, and muscle relaxation, making them effective in treating insomnia and other sleep disorders.
Option A, Zaleplon, is a nonbenzodiazepine hypnotic that acts specifically on the benzodiazepine site of the GABAA receptor. Option B, Flurazepam, is a benzodiazepine that also acts as a positive allosteric modulator of the GABAA receptor. Option C, Zolpidem, is a nonbenzodiazepine hypnotic that, like Zaleplon, targets the benzodiazepine site on the GABAA receptor.
Educationally, knowing the specific pharmacological properties of these drugs is vital for healthcare professionals to make informed decisions when selecting the most appropriate treatment for patients with sleep disorders. Understanding how these agents interact with the GABAA receptor provides a solid foundation for safe prescribing practices and optimizing patient outcomes.